Biblio Discovery — Demo Discovery Service

14 hasil untuk "Stuart Pocock"

Menampilkan 1–14 · 0,44 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

    Javed Butler; Milton Packer; Gerasimos S Filippatos dkk.

    European Heart Journal · 2021 · Inggris · OpenAlex Scopus

    AIMS: No therapy has shown to reduce the risk of hospitalization for heart failure across the entire range of ejection fractions seen in clinical practice. We assessed the influence of ejection fraction on the effect of the sodium-glucose cotransporter 2 inhibitor empagliflozin on heart failure…

  2. Artikel Jurnal Teks lengkap

    Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function

    Faiez M. Zannad; João Pedro Ferreira; Stuart Pocock dkk.

    Circulation · 2020 · Inggris · OpenAlex Scopus

    Background: In EMPEROR-Reduced (Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Reduced Ejection Fraction), empagliflozin reduced cardiovascular death or heart failure (HF) hospitalization and total HF hospitalizations, and slowed the progressive decline in kidney function…

  3. Artikel Jurnal Teks lengkap

    Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

    Milton Packer; Stefan D. Anker; Javed Butler dkk.

    Circulation · 2020 · Inggris · OpenAlex Scopus

    Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, with or without diabetes, but additional data are needed about the effect of the drug on inpatient and outpatient events that…

  4. Artikel Jurnal Teks lengkap

    Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status

    Stefan D. Anker; Javed Butler; Gerasimos S Filippatos dkk.

    Circulation · 2020 · Inggris · OpenAlex Scopus

    Background: Sodium-glucose cotransporter 2 inhibitors improve outcomes in patients with heart failure with reduced ejection fraction, but additional information is needed about whether glycemic status influences the magnitude of their benefits on heart failure and renal events. Methods: Patients…

  5. Artikel Jurnal Teks lengkap

    Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

    Milton Packer; Javed Butler; Faiez M. Zannad dkk.

    Circulation · 2021 · Inggris · OpenAlex Scopus

    BACKGROUND: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure with preserved ejection fraction, but additional data are needed about its effect on inpatient and outpatient heart failure events. METHODS: We randomly assigned…

  6. Artikel Jurnal Teks lengkap

    Risks to healthcare workers following tracheal intubation of patients with COVID‐19: a prospective international multicentre cohort study

    Kariem El‐Boghdadly; Danny J. N. Wong; Ruth Owen dkk.

    Anaesthesia · 2020 · Inggris · OpenAlex Scopus

    Healthcare workers involved in aerosol-generating procedures, such as tracheal intubation, may be at elevated risk of acquiring COVID-19. However, the magnitude of this risk is unknown. We conducted a prospective international multicentre cohort study recruiting healthcare workers participating in…

  7. Artikel Jurnal Teks lengkap

    Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement

    Samir Ramesh Kapadia; Raj Makkar; Martin B. Leon dkk.

    New England Journal of Medicine · 2022 · Inggris · OpenAlex Scopus

    BACKGROUND: Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may reduce the risk of stroke. METHODS: We randomly assigned patients with aortic stenosis…

  8. Artikel Jurnal Teks lengkap

    Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    Milton Packer; Stefan D. Anker; Javed Butler dkk.

    New England Journal of Medicine · 2020 · Inggris · OpenAlex Scopus

    BACKGROUNDSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.More evidence is needed regarding the effects of these drugs in patients across the broad spectrum of heart failure…

  9. Artikel Jurnal Teks lengkap

    Empagliflozin in Heart Failure with a Preserved Ejection Fraction

    Stefan D. Anker; Javed Butler; Gerasimos S Filippatos dkk.

    New England Journal of Medicine · 2021 · Inggris · OpenAlex Scopus

    BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain. METHODS: In this double-blind…

  10. Artikel Jurnal Teks lengkap

    Polypill Strategy in Secondary Cardiovascular Prevention

    Jose Maria Castellano; Stuart Pocock; Deepak L. Bhatt dkk.

    New England Journal of Medicine · 2022 · Inggris · OpenAlex Scopus

    BACKGROUND: A polypill that includes key medications associated with improved outcomes (aspirin, angiotensin-converting-enzyme [ACE] inhibitor, and statin) has been proposed as a simple approach to the secondary prevention of cardiovascular death and complications after myocardial infarction…